(Q42910592)

11 November 2017

title

The lack of target specificity of small molecule anticancer kinase inhibitors is correlated with their ability to damage myocytes in vitro (English)

1 reference

11 November 2017

Daywin Patel

2

1 reference

11 November 2017

Brian B. Hasinoff

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20832415

10 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20832415

10 July 2024

publication date

9 September 2010

1 reference

full work available at URL

11 November 2017

https://api.elsevier.com/content/article/PII:S0041008X10003145?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

https://api.elsevier.com/content/article/PII:S0041008X10003145?httpAccept=text/plain

10 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Toxicology and Applied Pharmacology

10 July 2024

published in

1 reference

11 November 2017

volume

249

1 reference

11 November 2017

issue

2

1 reference

11 November 2017

page(s)

132-139

1 reference

Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2

11 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention

10 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death

10 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics

10 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Molecular mechanisms of cardiovascular toxicity of targeted cancer therapeutics.

10 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

The cardiac safety of trastuzumab in the treatment of breast cancer

10 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Cardiovascular effects of tyrosine kinase inhibitors used for gastrointestinal stromal tumors

10 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

A small molecule-kinase interaction map for clinical kinase inhibitors

10 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Cardiotoxicity of the new cancer therapeutics--mechanisms of, and approaches to, the problem

10 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition

10 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Selectivity and therapeutic inhibition of kinases: to be or not to be?

10 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

10 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

The cardiotoxicity and myocyte damage caused by small molecule anticancer tyrosine kinase inhibitors is correlated with lack of target specificity

10 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Mechanisms of myocyte cytotoxicity induced by the multikinase inhibitor sorafenib

10 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Mechanisms of myocyte cytotoxicity induced by the multiple receptor tyrosine kinase inhibitor sunitinib

10 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

A quantitative analysis of kinase inhibitor selectivity

10 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.

10 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Sunitinib-induced cardiotoxicity is mediated by off-target inhibition of AMP-activated protein kinase

10 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration.

10 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Cardiotoxicity of antitumor drugs

10 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Selectively nonselective kinase inhibition: striking the right balance

10 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Inhibition of ALK signaling for cancer therapy

10 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Inhibition of ErbB2 by receptor tyrosine kinase inhibitors causes myofibrillar structural damage without cell death in adult rat cardiomyocytes

10 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

The dihydroorotase inhibitor 5-aminoorotic acid inhibits the metabolism in the rat of the cardioprotective drug dexrazoxane and its one-ring open metabolites

10 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Ste20-like kinase SLK displays myofiber type specificity and is involved in C2C12 myoblast differentiation

10 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

A gene atlas of the mouse and human protein-encoding transcriptomes

10 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies

10 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification

10 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management

10 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Targeting cancer with small molecule kinase inhibitors

10 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

Fgfr4 is required for effective muscle regeneration in vivo. Delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway

10 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.TAAP.2010.08.026

10 July 2024

Identifiers

1 reference

release_wjrpeshht5dpdm3gqxgczjus24

11 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wjrpeshht5dpdm3gqxgczjus24

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference